Funders › Foundation for Innovative New Diagnostics › 2022
Grants paid by Foundation for Innovative New Diagnostics, tax year 2022
EIN 98-0407553 · Switzerland · Form 990, Schedule I · NTEE H80
In tax year 2022, Foundation for Innovative New Diagnostics (EIN 98-0407553) reported 33 grants paid totaling $18,350,776. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2022
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2022 | Biomeme Philadelphia, PA | U | $4,015,000 | paid | Development of diagnostic tests | 202343199349316034 |
| 2022 | Transnational Technologiesinc Windermere, FL | U | $3,200,000 | paid | Supportmanufacturingandcommercializationof antigenrdtforcovid | 202343199349316034 |
| 2022 | Who-Paho Washington, DC | U | $2,275,676 | paid | Scaling-uptheuseofcovidantigenrapiddiagnost ic tests in Americas testsinAmericas testsinAmericas | 202343199349316034 |
| 2022 | Chai-Clintonhealthaccessinitiationinc Boston, MA | A | $2,007,458 | paid | TosupportTBeliminationefforts | 202343199349316034 |
| 2022 | Diagnosticconsultingnetworkinc Carlsbad, CA | A | $854,249 | paid | Developmentofdiagnostictests | 202343199349316034 |
| 2022 | Elizabeth Glaser Pediatric AIDS Foundation Washington, DC | B | $793,500 | paid | Evaluation of Antigen Rapid Diagnostic Tests | 202343199349316034 |
| 2022 | Columbiauniversity New York, NY | A | $792,000 | paid | ImplementationofcovidagRDTsinSouthSudan | 202343199349316034 |
| 2022 | Boston University Boston, MA | A | $655,323 | paid | Sponsored Research | 202343199349316034 |
| 2022 | Universityofnorthcarolina Chapelhill, NC | A | $644,191 | paid | Laboratorystrengtheningtosupportclinicalcare andresearch | 202343199349316034 |
| 2022 | Managementsciencesforhealth Cambridge, MA | U | $621,481 | paid | Undertake a project in the field of in vitro diagnostics and COVID | 202343199349316034 |
| 2022 | Program Appropriate Tech in Health Seattlle, WA | A | $312,583 | paid | Genomics trainings. Supporting the Africa CDC Workforce Development Effort for Pathogen Genomic Surveillance | 202343199349316034 |
| 2022 | Perkinelmer Health Sciences Inc Shelton, CT | U | $300,000 | paid | Develop and register with SRAs a Product that complies with the product requirements for commercialization | 202343199349316034 |
| 2022 | Dimagiinc Cambridge, MA | A | $252,335 | paid | Productionofmobilephoneappsthatcollectsdata fromrapidvitrodiagnostictestandthatcanaid anRDTuserininterpretingthetestresults | 202343199349316034 |
| 2022 | International Rescue Committee Inc New York, NY | B | $224,051 | paid | Supporting the use of rapid diagnostic tests for COVID-19 in humanitarian settings | 202343199349316034 |
| 2022 | Wolfgreenfieldandsackspc Boston, MA | U | $211,332 | paid | IPlandscapestudydirectedtothedetectionof NGAL/LCN-2biomarkers | 202343199349316034 |
| 2022 | Sherlock Biosciences Inc Watertown, MA | U | $202,000 | paid | COVID 19 molecular platform evaluation | 202343199349316034 |
| 2022 | Broadinstitute Cambridge, MA | A | $190,400 | paid | Developmentofarapide,point-of carediagnosticforhighsensitivitydetectionof Tuberculosis | 202343199349316034 |
| 2022 | Audere Seattle, WA | B | $147,704 | paid | Develop and make available digital tools for lay users to promote proper performance of CV-19 antigen RDTs and reporting of the results (ST project) | 202343199349316034 |
| 2022 | Exponent Natick, MA | D | $122,200 | paid | Technical Dossier review for submission of a regulatory package to the World Health Organization "WHO" | 202343199349316034 |
| 2022 | Universityofalabama Birmingham, AL | A | $119,140 | paid | Studytosupportclinicalperformanceevaluation ofGonorrhoea | 202343199349316034 |
| 2022 | Biomedical Research Institute Rockville, MD | A | $76,000 | paid | Supply of Schistomiasis parasites to FIND partner sites. | 202343199349316034 |
| 2022 | The Regents of the University of California La Jolla, CA | A | $66,493 | paid | Consulting services and blood culture due diligence support | 202343199349316034 |
| 2022 | Advention Business Partners Inc New York, NY | U | $62,507 | paid | To establish a framework by which to assess cost of goods sold (COGS), including reagent components, cost drivers, and margins for critical sequencing reagents | 202343199349316034 |
| 2022 | Boston Children's Hospital Boston, MA | A | $42,617 | paid | Research agreement for cross-cutting diseases | 202343199349316034 |
| 2022 | Harvard College Cambridge, MA | A | $32,849 | paid | Project agreement with Harvard for Seq&Treat mutations catalogue work | 202343199349316034 |
| 2022 | Drugs&diagnosticsfortropicaldiseases Sandiego, CA | A | $27,969 | paid | Developmentandcommercialisationofdiagnotic tests | 202343199349316034 |
| 2022 | University of Washington Seattle, WA | A | $27,022 | paid | assessment of HCV self testing | 202343199349316034 |
| 2022 | University of Massachusetts Amherst Stamherst, MA | A | $25,000 | paid | Material transfer agreement | 202343199349316034 |
| 2022 | Rutgers the State University of New Jersey Piscataway, NJ | A | $22,242 | paid | TB diagnostics including sample preparation and novel molecular tests for diagnosis | 202343199349316034 |
| 2022 | The Center for Affordable Health Bethesda, MD | U | $9,936 | paid | To provide material for publication | 202343199349316034 |
| 2022 | Sonavi Labs Inc Baltimore, MD | U | $6,800 | paid | Digital stethoscope for TB | 202343199349316034 |
| 2022 | Detectogen Inc Westborough, MA | U | $5,368 | paid | Supply of research material (antibodies) | 202343199349316034 |
| 2022 | Vera Solutions New York, NY | U | $5,350 | paid | Support on Salesforce tool utilization | 202343199349316034 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.